441 related articles for article (PubMed ID: 29769270)
41. The TLR4-TRIF pathway can protect against the development of experimental allergic asthma.
Shalaby KH; Al Heialy S; Tsuchiya K; Farahnak S; McGovern TK; Risse PA; Suh WK; Qureshi ST; Martin JG
Immunology; 2017 Sep; 152(1):138-149. PubMed ID: 28502093
[TBL] [Abstract][Full Text] [Related]
42. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
43. Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.
Orr MT; Fox CB; Baldwin SL; Sivananthan SJ; Lucas E; Lin S; Phan T; Moon JJ; Vedvick TS; Reed SG; Coler RN
J Control Release; 2013 Nov; 172(1):190-200. PubMed ID: 23933525
[TBL] [Abstract][Full Text] [Related]
44. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
[TBL] [Abstract][Full Text] [Related]
45. Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome.
Fernandes-Alnemri T; Kang S; Anderson C; Sagara J; Fitzgerald KA; Alnemri ES
J Immunol; 2013 Oct; 191(8):3995-9. PubMed ID: 24043892
[TBL] [Abstract][Full Text] [Related]
46. ATP Facilitates Staphylococcal Enterotoxin O Induced Neutrophil IL-1β Secretion
Hou F; Peng L; Jiang J; Chen T; Xu D; Huang Q; Ye C; Peng Y; Hu DL; Fang R
Front Immunol; 2021; 12():649235. PubMed ID: 34017331
[No Abstract] [Full Text] [Related]
47. A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo.
Pantel A; Cheong C; Dandamudi D; Shrestha E; Mehandru S; Brane L; Ruane D; Teixeira A; Bozzacco L; Steinman RM; Longhi MP
Eur J Immunol; 2012 Jan; 42(1):101-9. PubMed ID: 22002164
[TBL] [Abstract][Full Text] [Related]
48. A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93.
Orr MT; Beebe EA; Hudson TE; Moon JJ; Fox CB; Reed SG; Coler RN
PLoS One; 2014; 9(1):e83884. PubMed ID: 24404140
[TBL] [Abstract][Full Text] [Related]
49. Differential requirements of MyD88 and TRIF pathways in TLR4-mediated immune responses in murine B cells.
Yanagibashi T; Nagai Y; Watanabe Y; Ikutani M; Hirai Y; Takatsu K
Immunol Lett; 2015 Jan; 163(1):22-31. PubMed ID: 25448706
[TBL] [Abstract][Full Text] [Related]
50. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59.
Ellebedy AH; Lupfer C; Ghoneim HE; DeBeauchamp J; Kanneganti TD; Webby RJ
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2927-32. PubMed ID: 21270336
[TBL] [Abstract][Full Text] [Related]
51. The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection.
Gonçalves AC; Ferreira LS; Manente FA; de Faria CMQG; Polesi MC; de Andrade CR; Zamboni DS; Carlos IZ
Immunology; 2017 Jun; 151(2):154-166. PubMed ID: 28140444
[TBL] [Abstract][Full Text] [Related]
52. The combination of early and rapid type I IFN, IL-1α, and IL-1β production are essential mediators of RNA-like adjuvant driven CD4+ Th1 responses.
Madera RF; Wang JP; Libraty DH
PLoS One; 2011; 6(12):e29412. PubMed ID: 22206014
[TBL] [Abstract][Full Text] [Related]
53. Activation of NLRP3 inflammasome in macrophages by mycoplasmal lipoproteins and lipopeptides.
Saeki A; Sugiyama M; Hasebe A; Suzuki T; Shibata K
Mol Oral Microbiol; 2018 Aug; 33(4):300-311. PubMed ID: 29682880
[TBL] [Abstract][Full Text] [Related]
54. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
[TBL] [Abstract][Full Text] [Related]
55. Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor.
Iwata M; Ota KT; Li XY; Sakaue F; Li N; Dutheil S; Banasr M; Duric V; Yamanashi T; Kaneko K; Rasmussen K; Glasebrook A; Koester A; Song D; Jones KA; Zorn S; Smagin G; Duman RS
Biol Psychiatry; 2016 Jul; 80(1):12-22. PubMed ID: 26831917
[TBL] [Abstract][Full Text] [Related]
56. Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling.
Larena M; Holmgren J; Lebens M; Terrinoni M; Lundgren A
J Immunol; 2015 Apr; 194(8):3829-39. PubMed ID: 25786687
[TBL] [Abstract][Full Text] [Related]
57. Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.
Seubert A; Calabro S; Santini L; Galli B; Genovese A; Valentini S; Aprea S; Colaprico A; D'Oro U; Giuliani MM; Pallaoro M; Pizza M; O'Hagan DT; Wack A; Rappuoli R; De Gregorio E
Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11169-74. PubMed ID: 21690334
[TBL] [Abstract][Full Text] [Related]
58. ASC and NLRP3 impair host defense during lethal pneumonia caused by serotype 3 Streptococcus pneumoniae in mice.
van Lieshout MHP; de Vos AF; Dessing MC; de Porto APNA; de Boer OJ; de Beer R; Terpstra S; Florquin S; Van't Veer C; van der Poll T
Eur J Immunol; 2018 Jan; 48(1):66-79. PubMed ID: 28971472
[TBL] [Abstract][Full Text] [Related]
59. Inflammasome recognition of influenza virus is essential for adaptive immune responses.
Ichinohe T; Lee HK; Ogura Y; Flavell R; Iwasaki A
J Exp Med; 2009 Jan; 206(1):79-87. PubMed ID: 19139171
[TBL] [Abstract][Full Text] [Related]
60. NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.
Segovia JA; Chang TH; Winter VT; Coalson JJ; Cagle MP; Pandranki L; Bose S; Baseman JB; Kannan TR
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29061706
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
